Taysha Gene Therapies (TSHA) Amortizatization of Intangibles (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $400000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 32.89% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 11.67% year-over-year, with the annual reading at $1.4 million for FY2025, 11.67% up from the prior year.
  • Amortizatization of Intangibles hit $400000.0 in Q4 2025 for Taysha Gene Therapies, up from $312000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $400000.0 in Q4 2025 to a low of $274000.0 in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $317062.5 across 4 years, with a median of $306500.0 in 2023.
  • Biggest five-year swings in Amortizatization of Intangibles: dropped 20.78% in 2023 and later skyrocketed 32.89% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $284000.0 in 2022, then decreased by 3.52% to $274000.0 in 2023, then grew by 9.85% to $301000.0 in 2024, then surged by 32.89% to $400000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for TSHA at $400000.0 in Q4 2025, $312000.0 in Q3 2025, and $308000.0 in Q2 2025.